JP2024515165A5 - - Google Patents
Info
- Publication number
- JP2024515165A5 JP2024515165A5 JP2023558946A JP2023558946A JP2024515165A5 JP 2024515165 A5 JP2024515165 A5 JP 2024515165A5 JP 2023558946 A JP2023558946 A JP 2023558946A JP 2023558946 A JP2023558946 A JP 2023558946A JP 2024515165 A5 JP2024515165 A5 JP 2024515165A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- cancer
- antigen
- binding fragment
- sequence numbers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166663P | 2021-03-26 | 2021-03-26 | |
| US63/166,663 | 2021-03-26 | ||
| US202163294436P | 2021-12-29 | 2021-12-29 | |
| US63/294,436 | 2021-12-29 | ||
| PCT/US2022/021945 WO2022204514A1 (en) | 2021-03-26 | 2022-03-25 | Anti-klrg1 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515165A JP2024515165A (ja) | 2024-04-05 |
| JP2024515165A5 true JP2024515165A5 (https=) | 2025-04-15 |
Family
ID=81385062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558946A Pending JP2024515165A (ja) | 2021-03-26 | 2022-03-25 | 抗ｋｌｒｇ１抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240174754A1 (https=) |
| EP (1) | EP4314066A1 (https=) |
| JP (1) | JP2024515165A (https=) |
| KR (1) | KR20230162798A (https=) |
| AU (1) | AU2022246164A1 (https=) |
| BR (1) | BR112023019512A2 (https=) |
| CA (1) | CA3212311A1 (https=) |
| IL (1) | IL307241A (https=) |
| MX (1) | MX2023011102A (https=) |
| WO (1) | WO2022204514A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021004553A2 (pt) | 2018-09-17 | 2021-06-08 | Abcuro, Inc. | anticorpos anti-klrg1 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4474893A (en) | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
| JPS5896026A (ja) | 1981-10-30 | 1983-06-07 | Nippon Chemiphar Co Ltd | 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| DE3380726D1 (en) | 1982-06-24 | 1989-11-23 | Japan Chem Res | Long-acting composition |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US6030613A (en) | 1995-01-17 | 2000-02-29 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
| JP2019518791A (ja) * | 2016-06-03 | 2019-07-04 | ザ・ブリガム・アンド・ウィメンズ・ホスピタルＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ | Ｋｌｒｇ１シグナリングセラピー |
| WO2019169229A1 (en) * | 2018-03-01 | 2019-09-06 | Nextcure, Inc. | Klrg1 binding compositions and methods of use thereof |
| BR112021004553A2 (pt) * | 2018-09-17 | 2021-06-08 | Abcuro, Inc. | anticorpos anti-klrg1 |
| AU2020272939A1 (en) * | 2019-04-09 | 2021-11-11 | Abcuro, Inc. | Killer cell lectin-like receptor subfamily G member 1 (KLRG1) depleting antibodies |
-
2022
- 2022-03-25 CA CA3212311A patent/CA3212311A1/en active Pending
- 2022-03-25 JP JP2023558946A patent/JP2024515165A/ja active Pending
- 2022-03-25 BR BR112023019512A patent/BR112023019512A2/pt unknown
- 2022-03-25 KR KR1020237036278A patent/KR20230162798A/ko active Pending
- 2022-03-25 EP EP22718362.1A patent/EP4314066A1/en active Pending
- 2022-03-25 AU AU2022246164A patent/AU2022246164A1/en active Pending
- 2022-03-25 WO PCT/US2022/021945 patent/WO2022204514A1/en not_active Ceased
- 2022-03-25 IL IL307241A patent/IL307241A/en unknown
- 2022-03-25 US US18/552,515 patent/US20240174754A1/en active Pending
- 2022-03-25 MX MX2023011102A patent/MX2023011102A/es unknown